Masimo Current Ratio 2010-2025 | MASI

Current and historical current ratio for Masimo (MASI) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending March 31, 2025 was 2.17.
Masimo Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $1.18B $0.55B 2.17
2024-12-31 $1.23B $0.62B 1.98
2024-09-30 $1.28B $0.64B 2.01
2024-06-30 $1.14B $0.55B 2.09
2024-03-31 $1.17B $0.50B 2.31
2023-12-31 $1.23B $0.56B 2.19
2023-09-30 $1.24B $0.58B 2.14
2023-06-30 $1.21B $0.57B 2.11
2023-03-31 $1.26B $0.58B 2.16
2022-12-31 $1.31B $0.63B 2.08
2022-09-30 $1.25B $0.59B 2.12
2022-06-30 $1.16B $0.55B 2.10
2022-03-31 $1.23B $0.25B 4.82
2021-12-31 $1.24B $0.27B 4.63
2021-09-30 $1.14B $0.23B 4.99
2021-06-30 $1.05B $0.22B 4.78
2021-03-31 $0.98B $0.20B 4.99
2020-12-31 $1.10B $0.23B 4.71
2020-09-30 $1.16B $0.23B 4.98
2020-06-30 $1.09B $0.23B 4.80
2020-03-31 $0.98B $0.16B 6.23
2019-12-31 $1.00B $0.17B 5.78
2019-09-30 $0.93B $0.15B 6.23
2019-06-30 $0.86B $0.14B 6.35
2019-03-31 $0.85B $0.12B 7.02
2018-12-31 $0.79B $0.15B 5.39
2018-09-30 $0.74B $0.14B 5.12
2018-06-30 $0.65B $0.13B 5.05
2018-03-31 $0.60B $0.13B 4.55
2017-12-31 $0.56B $0.13B 4.32
2017-09-30 $0.55B $0.17B 3.17
2017-06-30 $0.57B $0.15B 3.89
2017-03-31 $0.56B $0.20B 2.75
2016-12-31 $0.51B $0.22B 2.30
2016-09-30 $0.33B $0.14B 2.25
2016-06-30 $0.30B $0.12B 2.46
2016-03-31 $0.32B $0.12B 2.65
2015-12-31 $0.30B $0.13B 2.26
2015-09-30 $0.30B $0.11B 2.66
2015-06-30 $0.31B $0.11B 2.71
2015-03-31 $0.32B $0.12B 2.69
2014-12-31 $0.30B $0.12B 2.40
2014-09-30 $0.30B $0.24B 1.25
2014-06-30 $0.27B $0.17B 1.59
2014-03-31 $0.29B $0.10B 2.96
2013-12-31 $0.27B $0.10B 2.62
2013-09-30 $0.26B $0.10B 2.53
2013-06-30 $0.24B $0.09B 2.54
2013-03-31 $0.23B $0.10B 2.37
2012-12-31 $0.22B $0.09B 2.45
2012-09-30 $0.26B $0.08B 3.08
2012-06-30 $0.27B $0.08B 3.55
2012-03-31 $0.27B $0.09B 2.98
2011-12-31 $0.26B $0.08B 3.46
2011-09-30 $0.28B $0.07B 4.19
2011-06-30 $0.25B $0.06B 4.08
2011-03-31 $0.23B $0.06B 3.67
2010-12-31 $0.22B $0.07B 3.10
2010-09-30 $0.25B $0.07B 3.55
2010-06-30 $0.23B $0.06B 3.54
2010-03-31 $0.22B $0.07B 3.01
2009-12-31 $0.29B $0.06B 4.87
2009-09-30 $0.28B $0.06B 4.87
2009-06-30 $0.25B $0.05B 4.75
2009-03-31 $0.24B $0.06B 4.02
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.120B $2.094B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $191.291B 83.79
Thermo Fisher Scientific (TMO) United States $154.123B 18.64
Edwards Lifesciences (EW) United States $45.878B 30.08
Alcon (ALC) Switzerland $43.312B 29.27
IDEXX Laboratories (IDXX) United States $42.730B 49.10
DexCom (DXCM) United States $33.851B 52.32
IQVIA Holdings (IQV) United States $27.242B 15.26
Mettler-Toledo (MTD) United States $24.618B 29.28
STERIS (STE) Ireland $23.490B 25.87
Waters (WAT) United States $20.972B 29.59
SONOVA HOLDING (SONVY) Switzerland $17.819B 0.00
Hologic (HOLX) United States $14.487B 15.74
Sysmex ADR (SSMXY) Japan $10.827B 30.71
Penumbra (PEN) United States $9.930B 77.94
Globus Medical (GMED) United States $7.933B 18.90
Glaukos (GKOS) United States $5.795B 0.00
Teleflex (TFX) United States $5.279B 8.71
TransMedics (TMDX) United States $4.446B 96.65
Integer Holdings (ITGR) United States $4.276B 22.41
PROCEPT BioRobotics (PRCT) United States $3.149B 0.00
LivaNova (LIVN) United Kingdom $2.495B 14.85
Veracyte (VCYT) United States $2.144B 30.09
Nihon Kohden (NHNKY) Japan $2.041B 23.41
Elekta AB (EKTAY) Sweden $1.933B 17.38
Alphatec Holdings (ATEC) United States $1.620B 0.00
Artivion (AORT) United States $1.332B 124.76
Tandem Diabetes Care (TNDM) United States $1.262B 0.00
OPKO Health (OPK) United States $1.047B 0.00
Pulse Biosciences (PLSE) United States $1.014B 0.00
Integra LifeSciences Holdings (IART) United States $0.955B 5.08
SiBone (SIBN) United States $0.785B 0.00
IRadimed (IRMD) United States $0.774B 39.25
Beta Bionics (BBNX) United States $0.653B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.565B 8.78
Mesa Laboratories (MLAB) United States $0.538B 12.62
OrthoPediatrics (KIDS) United States $0.519B 0.00
RxSight (RXST) United States $0.515B 0.00
AxoGen (AXGN) United States $0.478B 0.00
Delcath Systems (DCTH) United States $0.473B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.435B 0.00
Semler Scientific (SMLR) United States $0.429B 11.42
AngioDynamics (ANGO) United States $0.397B 0.00
Pacific Biosciences Of California (PACB) United States $0.387B 0.00
Treace Medical Concepts (TMCI) United States $0.362B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
ClearPoint Neuro (CLPT) United States $0.330B 0.00
Alpha Tau Medical (DRTS) Israel $0.253B 0.00
908 Devices (MASS) United States $0.241B 0.00
Tactile Systems Technology (TCMD) United States $0.240B 14.56
Neuronetics (STIM) United States $0.232B 0.00
Sight Sciences (SGHT) United States $0.222B 0.00
Biosig Technologies (BSGM) United States $0.209B 0.00
Inogen (INGN) United States $0.190B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
Rapid Micro Biosystems (RPID) United States $0.157B 0.00
CVRx (CVRX) United States $0.152B 0.00
LENSAR (LNSR) United States $0.150B 0.00
Anteris Technologies Global (AVR) Australia $0.146B 0.00
Accuray (ARAY) United States $0.142B 0.00
Lucid Diagnostics (LUCD) United States $0.127B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.080B 48.60
EnVVeno Medical (NVNO) United States $0.071B 0.00
InspireMD (NSPR) United States $0.070B 0.00
EDAP TMS S.A (EDAP) France $0.062B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Spectral AI (MDAI) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.038B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.12
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00